资源描述：
《生物技术药物免疫原性的评价及面临的挑战》由会员上传分享，免费在线阅读，更多相关内容在教育资源-天天文库。
1、生物技术药物免疫原性的评价及面临的挑战ChineseJournalofNewDrugs2007,Vo1.16No.3[2][3]4]5]6]:7][8][9]:10]:12]付立杰.毒理学在中国现代化建设中面临的机遇与挑战[J].中国药理学与毒理学杂志,2000,14(5):321—335.CROUCHSPM.High—thmughputcytotoxicityscreening:hitandmiss[J].DrugDiscovToday,2001,6(12):$48一$53.廖明阳,吴纯启.我国未来的药物毒理学研究[M]
2、//吴镭.2000药学科学前沿与发展方向北京:中国医药科技出版社.2000:74—84.HUGESD.Drugdiscoverytodayandthestatus[J].DrugDiscovToda),1996,1(1):1.RYFFELB.Cytokineknockoutmice:possibleappllcafionintox—icologiealresearch[J].Toxicology,1995,105(1):69—80.MAYM.Learningtoknockoutmaleinfertility[J].Envi
3、ronHealthPerspect,1998,106(3):A132—133.BRUCERD.Aconfirmatorystudyoftheup—and—downforacuteoraltoxicitytesting[J].FundamApplToxicol,1987,8(1):97—100.FLINTOP.Invitrotestforteratogens:desirableendpoints,testbatteriesandeu~entstatusofthemicromassteratogentest[J]ReprodT
4、oxicol,1993,7(Suppl1):S103一S111.HUBBARDSA,GREENMHL.GATEHOUSED,eta1.Thefluctuationtestinbacteria[M]//KIBEYBJ,LEGATORM,NICHOLSW,eta1.Handbookofmutagenicitytestprocedures.Amsterdam:Elesevier,1984:142—160.MARONDM.AMESBN.RevisedmethodsfortheSalmomellamutagenicitytest[J
5、].MutatRes,1983,113(3/4):173—215.QUILLARDETP,HOFNUNGM.TheSOSChromotest,acolori—metricbacterialassayaherration[J]MutatRes,1987,190[13][14][15][16][17][18][19][20]中国新药杂志2007年第16卷第3期(1):51—57.李勇,张天宝.发育毒理学研究方法和实验技术[M].北京:北京医科大学出版社.2000:125—127.FLINTOP.Aninvitrotestfor
6、teratogensusingcuhuresofratem—bryocells[M]//ATTERW1LLCK,STEELECE.Invitrometh—odsintoxicology.Cambridge:CambrigeUniversityPress,1987:339—363.INOUETToxicogenomics,anewparadigmoftoxicology[M]//INOUET,PENNIEMD.T0xic0gen0m.Tokyo:Springer—Ver—lag.2003:3一l1.CUNNINGHAMMJ.
7、Genomicsandproteomics—thenewmillenni—umofdrugdiscoveryanddevelopment[J]JPharmacolToxieolMethods,2000,44(1):291—300.WASINGERVC.CORDWELLSJ.CERPA—POLJAKA.eta1.Progresswithgene—productmappingoftheMollicutes:Mycoplas—magenitalium[J].Electrophoresis,1995,16(7):1090—1094
8、.BANDARALR,KENNEDYS.T0xic叩r0te0mics—anewpreclin—icaltool[J].DDT,2002,7(7):411—417.WALGRENJL.THOMPSONDC.Applicationofproteomictech—nologiesinthedrugdevel
